◼ Archived
Business
CSL pays $355M to co-develop Alentis’ phase 2-stage fibrosis drug
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 trends tracked about this subject — the full history, oldest to newest below.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.